Endothelial dysfunction in hypertension: Fact or fancy?

Journal of Cardiovascular Pharmacology

Volumn 32, Issue SUPPL. 3, 1998, Pages

  Taddei, Stefano ^a   Virdis, Agostino ^a   Ghiadoni, Lorenzo ^a   Salvetti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Atherosclerosis; Endothelium; Hypertension; Thrombosis Nitric oxide

Indexed keywords

ACETYLCHOLINE; ASCORBIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; N(G) METHYLARGININE; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME ACTIVATION; HUMAN; HYPERTENSION; PRIORITY JOURNAL; THROMBOEMBOLISM; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION;

EID: 0032417396     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Lüscher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function. Boca Raton, FL: CRC Press, 1990:1-215.
2. Furchgott RF, Zawadzky JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
4. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
5. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991;351:714.
6. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986;250: H1145-9.
7. Miller VM, Vanhoutte PM. Endothelium-dependent contractions to arachidonic acid are mediated by products of cyclooxygenase. Am J Physiol 1985;248:H432-7.
8. 2. J Pharmacol Exp Ther 1986;236:535-41.
9. Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 1989;257:H33-7.
10. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-6.
11. Lüscher TF, Noll G. Endothelial function as an end-point in interventional trials: concepts, method and current data. J Hypertens 1996;14(Suppl 2):S111-21.
12. Linder L, Kiowski W, Buhler FR, Lüscher TF. Indirect evidence for the release of endolhelium-derived relaxing factor in the human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990;81:1762-7.
13. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
14. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993;87:1468-74.
15. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993;87: 1475-81.
16. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 1993;21:1145-51.
17. Taddei S, Virdis A, Mattel P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993;21:929-33.
18. Taddei S, Mattel P, Virdis A, Sudano I, Ghiadoni L, Salvetti A. Effect of potassium on vasodilation to acetylcholine in essential hypertension. Hypertension 1994;23:485-90.
19. Creager MA, Roddy MA. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension 1994; 24:499-505.
20. Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation 1995;92:2911-8.
21. Panza JA, Garcìa CE, Kilcoyne CM, Quyyumi AA, Cannon RO. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 1995;91:1732-8.
22. Taddei S, Virdis A, Mattei P, et al. Aging and endothelial function in normotensive subjects and essential hypertensive patients. Circulation 1995;91:1981-7.
23. Taddei S, Virdis A, Ghiadoni L, et al. Menopause is associated with endothelial dysfunction in normotensive and essential hypertensive humans. Hypertension 1996;28:576-82.
24. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 1997;29(pt 2):274-9.
25. Rossi M, Taddei S, Fabbri A, et al. Cutaneous vasodilation to acetylcholine in patients with essential hypertension. J Cardiovasc Pharmacol 1997;29:406-11.
26. Falloon BJ, Haegerty AM. In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension 1994;24:16-23.
27. Zeiher AM, Drexter H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993;92:652-62.
28. Egashira K, Suzuki S, Hirooka Y, et al. Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Hypertension 1995; 25:201-6.
29. Mimram A, Ribstein J, DuCailar G. Contrasting effects of antihypertensive treatment on the renal response to L-arginine. Hypertension 1995;26(pt 1):937-41.